Mopic / Shutterstock.com
16 October 2015Americas
BIO Latin America: Eli Lilly criticises innovation bar
A counsel for pharmaceutical company Eli Lilly has said that recent court decisions, including Ariosa v Sequenom, will create a bar to innovation.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
15 October 2015 The US’s consul general in Rio de Janeiro has urged the US and Brazilian governments to work together to tackle the long delay in biotechnology-related patents being granted at Brazil’s intellectual property office.
Americas
16 October 2015 A director of a research initiative pioneered by pharmaceutical company GSK has said that recognising the initial owner of intellectual property is at the heart of its priorities.
Editor's picks
Editor's picks
Americas
15 October 2015 The US’s consul general in Rio de Janeiro has urged the US and Brazilian governments to work together to tackle the long delay in biotechnology-related patents being granted at Brazil’s intellectual property office.
Americas
16 October 2015 A director of a research initiative pioneered by pharmaceutical company GSK has said that recognising the initial owner of intellectual property is at the heart of its priorities.
Americas
15 October 2015 The US’s consul general in Rio de Janeiro has urged the US and Brazilian governments to work together to tackle the long delay in biotechnology-related patents being granted at Brazil’s intellectual property office.
Americas
16 October 2015 A director of a research initiative pioneered by pharmaceutical company GSK has said that recognising the initial owner of intellectual property is at the heart of its priorities.